These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10360152)

  • 1. Allergic reactions from injectable methadone.
    Uehlinger C; Hauser C
    Am J Psychiatry; 1999 Jun; 156(6):973. PubMed ID: 10360152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dangers of intravenous use of peroral methadone solutions].
    Shilo L; Liebermann N; Solomon G; Shenkman L
    Harefuah; 1986 Sep; 111(5-6):126-7. PubMed ID: 3804060
    [No Abstract]   [Full Text] [Related]  

  • 3. Three estimators of the probability of opiate use from incomplete data.
    Gross AJ
    NIDA Res Monogr; 1992; 128():82-94; discussion 95-6. PubMed ID: 1436018
    [No Abstract]   [Full Text] [Related]  

  • 4. Methadone.
    Wodak AD; Monheit BM
    Med J Aust; 1990 Dec 3-17; 153(11-12):742. PubMed ID: 2247007
    [No Abstract]   [Full Text] [Related]  

  • 5. Symptom complaints of patients prescribed either oral methadone or injectable heroin.
    Dürsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA
    J Subst Abuse Treat; 2010 Jun; 38(4):328-37. PubMed ID: 20206457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a methadone rehabilitation program.
    Graham-Bafus S; Allen RH; Gordon JR
    Psychol Rep; 1984 Aug; 55(1):99-106. PubMed ID: 6484100
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing opioid detoxification: rearranging deck chairs on the Titanic.
    Stein MD; Friedmann PD
    J Addict Dis; 2007; 26(2):1-2. PubMed ID: 17594992
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical mismanagement in public methadone programs.
    Addiss SS; Horosko S
    Conn Med; 1994 Mar; 58(3):173-4. PubMed ID: 8039382
    [No Abstract]   [Full Text] [Related]  

  • 10. Retention rates among New York City methadone patients: a response to Bayer and Koenigsberg.
    Des Jarlais DC
    Int J Addict; 1982 Jul; 17(5):929-30. PubMed ID: 7129708
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampin-induced methadone withdrawal in AIDS.
    Holmes VF
    J Clin Psychopharmacol; 1990 Dec; 10(6):443-4. PubMed ID: 2286719
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of AIDS through methadone maintenance treatment.
    Ball JC; Lange WR; Myers CP; Friedman SR
    J Health Soc Behav; 1988 Sep; 29(3):214-26. PubMed ID: 3241064
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
    Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
    Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pros and cons of methadone?].
    Lôo H; Laqueille X
    Rev Prat; 2002 Oct; 52(15):1629-30. PubMed ID: 12434589
    [No Abstract]   [Full Text] [Related]  

  • 17. Driving capacity of patients treated with methadone and slow-release oral morphine.
    Giacomuzzi SM; Ertl M; Vigl A; Riemer Y; Günther V; Kopp M; Pilsz W; Haaser W
    Addiction; 2005 Jul; 100(7):1027. PubMed ID: 15955021
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems in methadone treatment: the influence of reference groups.
    Hunt DE; Lipton DS; Goldsmith DS; Strug DL
    NIDA Res Monogr; 1984; 46():8-22. PubMed ID: 6427626
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone maintenance: an update.
    Senay EC
    NIDA Res Monogr; 1983 Apr; 43():51-8. PubMed ID: 6410279
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.